Curio Bioscience

Palo Alto, United States Founded: 2021 • Age: 5 yrs Acquired By Takara Bio
Spatial omics solutions are provided for discovery research.
Request Access

About Curio Bioscience

Curio Bioscience is a company based in Palo Alto (United States) founded in 2021 by Christina Fan, Ari Chaney, and Stephen Fodor was acquired by Takara Bio in January 2025.. Curio Bioscience offers products and services including Seeker and Trekker. Curio Bioscience operates in a competitive market with competitors including Cellworks, Genuity Science, ICarbonX, Rhelixa and Geneyx, among others.

  • Headquarter Palo Alto, United States
  • Founders Christina Fan, Ari Chaney, Stephen Fodor
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $2 M (USD), Grant

    Mar 15, 2022

  • Investors
    HHS

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Takara Bio

    (Jan 15, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Curio Bioscience

Curio Bioscience offers a comprehensive portfolio of products and services, including Seeker and Trekker. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides high-resolution RNA expression mapping for fresh frozen tissues.

Enables single-cell analysis with spatial orientation for genomics research.

Funding Insights of Curio Bioscience

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $2.0M
  • First Round

    (15 Mar 2022)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2022 Amount Grant - Curio Bioscience Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Curio Bioscience

Curio Bioscience has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Takara Bio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Developer of gene-based therapies as well as contract services for the industrial and agricultural sector
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Curio Bioscience

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Curio Bioscience

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Curio Bioscience Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Curio Bioscience

Curio Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellworks, Genuity Science, ICarbonX, Rhelixa and Geneyx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biosimulation platform developed for therapeutic design in life sciences.
domain founded_year HQ Location
AI-based omics data analysis solutions are provided to researchers.
domain founded_year HQ Location
Bioinformatics platforms are provided for health management and drug development.
domain founded_year HQ Location
Integrated genomic analysis platform for epigenome data is provided.
domain founded_year HQ Location
Provider of a clinical genetics data management platform for hospitals and genetic labs
domain founded_year HQ Location
Omics clinical data is analyzed through an online platform.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Curio Bioscience

Frequently Asked Questions about Curio Bioscience

When was Curio Bioscience founded?

Curio Bioscience was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Where is Curio Bioscience located?

Curio Bioscience is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.

Who is the current CEO of Curio Bioscience?

Stephen Fodor is the current CEO of Curio Bioscience. They have also founded this company.

What does Curio Bioscience do?

Curio Bioscience was founded in 2021 and is based in Palo Alto, United States. Spatial omics solutions are offered for discovery research within the biotechnology sector. Products including the Curio Seeker bioinformatics pipeline are provided to support spatial transcriptomics analysis. High-resolution mapping is enabled through these tools, by which insights into complex cellular biology are uncovered by researchers.

Who are the top competitors of Curio Bioscience?

Curio Bioscience's top competitors include Watershed, Cellworks and Rhelixa.

What products or services does Curio Bioscience offer?

Curio Bioscience offers Seeker and Trekker.

Who are Curio Bioscience's investors?

Curio Bioscience has 2 investors. Key investors include HHS, and Takara Bio.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available